Alex Hanly – CEO – Lithium Universe (ASX:LU7) objective is to construct a Lithium Project in Québec with utmost speed, and to assist Canada facilitate the transition towards cleaner energy.
Copyright 2023 – Finance News Network
03 Nov 2023 - NOVONIX (ASX:NVX) CEO, Chris Burns, discusses securing a $100 million grant from the DOE, the company's Riverside facility expansion, graphite's future amidst China's export controls, and the pivotal role of synthetic graphite in clean energy.
21 Mar 2023 - Centuria Capital Group Limited (ASX:CNI) Joint CEO John McBain discusses the rising interest rate environment, the company's expansion into the healthcare and agricultural sectors, the acquisition of Primewest, and possible future M&A opportunities.
30 Jul 2024 - Dr Mark Cooksey - CEO & Managing Director - ABx Group (ASX:ABX) is a uniquely positioned, Australian company delivering materials for a cleaner future. The two current areas of focus are the creation of an ionic adsorption clay rare earth project in northern Tasmania and the establishment of a plant to produce hydrogen fluoride and aluminium fluoride from recycled industrial waste, to replace imports (ALCORE).
16 Aug 2023 - Tom Spurling - Executive Director - Nova Eye Medical (ASX:EYE) is introducing a comprehensive portfolio of novel glaucoma treatment options which span the entire disease process – enabling physicians to intervene earlier, and more often, in the treatment of glaucoma.
10 Oct 2023 - Jon Price - Managing Director - Richmond Vanadium Technology (ASX:RVT) is an Australian minerals development company which is advancing the Richmond – Julia Creek Vanadium Project in Queensland through a Bankable Feasibility Study.
10 Jul 2024 - The Honourable Shane Jones discusses the New Zealand government's pro-mining strategy. Topics touched on include: the rationale behind invigorating the resources sector, statutory reforms to boost investment, and commodities New Zealand possesses.
13 May 2020 - Elixinol Global (ASX:EXL) CEO, Oliver Horn talks about its strategy to create a global nutraceuticals brand, with a focus on higher margin, consumer branded products, new management team, capital raising and FY 20 outlook.
19 Aug 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress with the company's IMP761 drug, which is potentially active in more than 90% of autoimmune diseases.